Breast Ultrasound Market

Introduction of the Breast Ultrasound Market Report

The breast ultrasound is an imaging test that a doctor may order to check for tumors or other breast abnormalities. This test utilizes high-frequency sound waves to produce detailed images of the inside of the breast. To conduct a conventional breast ultrasound, a healthcare professional uses a handheld device called a transducer to create images of the breast.

To have an edge over the competition by knowing the market dynamics and current trends of “Breast Ultrasound Market”, request for Sample Report here

Market Dynamic

Key Drivers and Emerging Trends

Increasing incidences of breast cancer across the globe is forecast to propel the breast ultrasound market growth. According to the World Health Organization (WHO), breast cancer impacts nearly 2.1 million women every year. It also reported that, in 2018, 627,000 women died from the disease, which is about 15.0% of all deaths from cancer among women. Changing eating habits, rising cases of obesity, lifestyle disorders, ongoing technological advancements and increasing initiatives by the government are some other factors driving the market growth. For example, in 2018, GE Healthcare introduced Invenia Automated Breast Ultrasound (ABUS) 2.0 in the U.S., primarily designed to detect tumors in dense breast tissues. In addition, the breast ultrasound market size is expanding because of the lower cost, wide availability, aging population, and government initiatives to spread awareness about breast cancer and its diagnosis. Leading companies in the breast ultrasound market are innovating technologically advanced products to expand their presence in the market. However, as per the breast ultrasound market global forecast, the high cost of ultrasound tests aided by the adoption of technologically advanced products for better diagnosis will restrain the market growth. Additionally, inadequate knowledge, strict regulatory approval procedures, and lack of reimbursement coverage are other factors impeding the breast ultrasound market size.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Product – Segment Analysis

Based on the Product, the Automated segment is expected to grow at a higher CAGR during the forecast period. The growth of this segment can be attributed to the availability of a huge number of products, equipments, rapid technological advancements, and user-friendly features of this device. Automated breast ultrasound (ABUS) is a development in the technological field of ultrasound imaging that was developed to overcome the concern of operator dependence of conventional ultrasound scanning by standardization of the images acquired. This is obtained by volumetric acquisition of multiple ultrasound images of the breast that can be saved and post-processed, i.e., 3D and multiplaner reformatting, for later reading and evaluation. Despite the fact that automated breast ultrasound (ABUS) has been around for more than a decade yet conventional systems provided poor image quality for proper interpretation. Recent technological developments in ABUS systems with the installation of high-frequency transducers allowed for the reproduction of pictures with superior quality in a short time as well.

End-Use – Segment Analysis

Based on the End-Use, Diagnostics Imaging Laboratories segment is expected to grow at a high CAGR during the forecast period. The growth of this segment can be attributed due to the rising number of diagnostic centers, increasing demand for imaging techniques, and the high global prevalence of breast cancer among women. Moreover, diagnostic imaging assists doctors in analyzing the condition and determine the medical course. Hence, such factors are expected to further boost the growth of the segment.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

Regional – Segment Analysis:

Based on the region, the North-America region is projected to dominate the market during the forecast period. For instance, as per Breastcancer.org, around 12.0% of women are diagnosed with invasive breast cancer over the course of their lifetime. In 2021, an estimated 281,550 new cases of invasive breast cancer are expected to be detected in women in the U.S., along with 49,290 new cases of non-invasive (in situ) breast cancer. As of January 2021, there were more than 3.8 million women with a past history of breast cancer in the U.S.; this comprises women currently being treated and those who have finished treatment. Breast cancer is the most commonly prevalent cancer among American women. In addition to that, in 2021, it’s estimated that about 30% of newly diagnosed cancers in women will be breast cancers. Such a high instance is forecasted to drive the regional breast ultrasound market share during the forecast period.

Top Market Players

Various notable players operating in the market include GENERAL ELECTRIC, Hitachi, Ltd., Koninklijke Philips N.V., Siemens Healthcare GmbH, TELEMED Medical Systems, CANON MEDICAL SYSTEMS CORPORATION, FUKUDA DENSHI, Hologic, Inc., CMR Naviscan, Supersonic Imagine, among others. 

Key Developments:

• • In 2022, Royal Philips, an international leader in health technology, declared the expansion of U.S. Food & Drug Administration 510(k) market clearance for remote diagnostic use on additional mobile platforms.
  • In 2021, Hologic, Inc. launched the latest SuperSonic MACH 20 ultrasound system for the expansion of its ultrasound portfolio. With this innovation Hologic offers three tiers of ultrasound technology, to ensure the access to more facilities and offer customized ultrasound solutions to cater the needs of unique imaging. The system is designed to improve efficiency and diagnostic accuracy to offer an intuitive user experience.
  • In 2019, Hologic, Inc. procured 46.0% share of Supersonic Imagine to combine the latter’s ultrasound technology and product with its resources to offer better and technologically advanced products to breast cancer patients. This acquisition is anticipated to increase the Hologic’s foothold in the near future.
  • In 2019, Supersonic Imagine announced the new generation of its Aixplorer Mach 30 breast ultrasound solution at the Society of Breast Imaging/American College of Radiology (SBI/ACR) Breast Imaging Symposium in Hollywood. It is equipped with the next generation of ShearWave Plus (SWE Plus) elastography and provides an advanced breast imaging solution with enhanced speed of acquisition.
  • In 2018, CMR Naviscan and the Mayo Clinic signed an exclusive licensing and commercialization agreement for a group of molecular breast imaging technologies developed at Mayo Clinic.

Segments covered in the Report:

The global Breast Ultrasound market has been segmented on the basis of Product, End-Use, and regions. Based on Product, the market is segmented into Conventional and Automated. Based on End-Use, the market is segmented into Hospital and Diagnostics Imaging Laboratories. 

For detailed scope of the “Breast Ultrasound Market” report request a Sample Copy of the report

Key questions answered in this research report:

• • At what pace is global Breast Ultrasound market growing? What will be the growth trend in the future?
  • What are the key drivers and restraints in Breast Ultrasound market? What will be the impact of drivers and restraints in the future?
  • What are the regional revenues and forecast breakdowns? Which are the major regional revenue pockets for growth in the global Breast Ultrasound market?
  • Which Product generated maximum revenues in 2020 and identify the most promising Product during the forecast period?
  • What are the various End-Use areas of global Breast Ultrasound market and how they are poised to grow?
  • What companies are the major participants in this market and their business strategies, how does the competitive landscape look like?

Report Coverage	Details
Market Base Year	2020
Market Forecast Period	2021-2028
Market Revenues Currency	USD Million
Base Year & Forecast Units	Revenues (USD Million)
Market Segment	By Product, By End-Use, By Region
Regional Coverage	Asia Pacific, Europe, North America, and RoW
Companies Profiled	GENERAL ELECTRIC, Hitachi, Ltd., Koninklijke Philips N.V., Siemens Healthcare GmbH, TELEMED Medical Systems, CANON MEDICAL SYSTEMS CORPORATION, FUKUDA DENSHI, Hologic, Inc., CMR Naviscan, Supersonic Imagine, among others; a total of 10 companies covered.
25% Free Customization Available	We will customize this report up to 25% as a free customization to address our client’s specific requirements

Market Segmentation

Global Breast Ultrasound Market by Product

• • Conventional
  • Automated

Global Breast Ultrasound Market by End-Use

• • Hospital
  • Diagnostics Imaging Laboratories

Global Breast Ultrasound Market by Region

• • North America Breast Ultrasound Market (Option 1: As a part of the free 25% customization)
    • By Product
    • By End-Use
    • US Market All-Up
    • Canada Market All-Up
  • Europe Breast Ultrasound Market (Option 2: As a part of the free 25% customization)
    • By Product
    • By End-Use
    • UK Market All-Up
    • Germany Market All-Up
    • France Market All-Up
    • Spain Market All-Up
    • Rest of Europe Market All-Up
  • Asia-Pacific Breast Ultrasound Market (Option 3: As a part of the free 25% customization)
    • By Product
    • By End-Use
    • China Market All-Up
    • India Market All-Up
    • Japan Market All-Up
    • Rest of APAC Market All-Up
  • RoW Breast Ultrasound Market (Option 4: As a part of the free 25% customization)
    • By Product
    • By End-Use
    • Brazil Market All-Up
    • South Africa Market All-Up
    • Saudi Arabia Market All-Up
    • UAE Market All-Up
    • Rest of world (remaining countries of the LAMEA region) Market All-Up

Major Players Operating in the Breast Ultrasound (Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)

• • GENERAL ELECTRIC
  • Hitachi, Ltd.
  • Koninklijke Philips N.V.
  • Siemens Healthcare GmbH
  • TELEMED Medical Systems
  • CANON MEDICAL SYSTEMS CORPORATION
  • FUKUDA DENSHI
  • Hologic, Inc.
  • CMR Naviscan
  • Supersonic Imagine